GLP-1 Receptor Agonist Therapy: Clinical Trials

3 trials of GLP-1 Receptor Agonist Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 1 recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1

Follow this drug Literature Review of GLP-1 Receptor Agonist Therapy trials Research Report on GLP-1 Receptor Agonist Therapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
NAION in Non-Diabetic Obese Patients Using GLP-1 Receptor Agonists: A Real-World Study
GLP-1 Receptor Agonist Therapy - Non-arteritic Anterior Ischemic Optic Neuropathy Obesity, Obesity
Not yet recruitingIstanbul Saglik Bilimleri University282026-09-212026-09-29
GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity
GLP-1 receptor agonist therapy - Morbid Obesity, Anorectal Diseases
Not yet recruitingGazi University1002026-08-012026-06-25
Tirzepatide Impact Assessment Study
GLP-1 Receptor Agonist Therapy, Structured Lifestyle Intervention - Obesity & Overweight, Cardiometabolic Health Indicators
Not applicableRecruitingTexas Tech University272025-01-022026-07-31

Conditions studied

Obesity (3)  ·  Behavior, Addictive (1)  ·  Constipation (1)  ·  Diarrhea (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Feeding and Eating Disorders (1)  ·  Fissure in Ano (1)  ·  Hemorrhoids (1)  ·  Obesity, Morbid (1)  ·  Optic Nerve Diseases (1)  ·  Optic Neuropathy, Ischemic (1)  ·  Overweight (1)  ·  Psychological Well-Being (1)  ·  Rectal Diseases (1)

Sponsors

Gazi University (1)  ·  Istanbul Saglik Bilimleri University (1)  ·  Texas Tech University (1)

Countries

Turkey (Türkiye) (2)  ·  United States (1)

Results publications

PMID 33625476, PMID 36700417, PMID 39649679